[1]戴敏,郑志坤,李亚娣,等.虹膜周边前后节沟通术在恶性青光眼患者治疗中的应用[J].眼科新进展,2020,40(1):034-37.[doi:10.13389/j.cnki.rao.2020.0008]
 DAI Min,ZHENG Zhikun,LI Yadi,et al.Effect of Zonulo-hyaloido-vitrectomy in treatment of malignant glaucoma[J].Recent Advances in Ophthalmology,2020,40(1):034-37.[doi:10.13389/j.cnki.rao.2020.0008]
点击复制

虹膜周边前后节沟通术在恶性青光眼患者治疗中的应用/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年1期
页码:
034-37
栏目:
应用研究
出版日期:
2020-01-05

文章信息/Info

Title:
Effect of Zonulo-hyaloido-vitrectomy in treatment of malignant glaucoma
作者:
戴敏郑志坤李亚娣胡竹林
650021 云南省昆明市,云南省第二人民医院眼科、云南省眼科医院、云南省眼科研究所、云南省眼科疾病防治研究重点实验室、云南省第二人民医院白内障与眼底疾病防治省创新团队、云南省姚克专家工作站、云南省眼部疾病临床医学研究中心、云南省眼病临床医学中心
Author(s):
DAI MinZHENG ZhikunLI YadiHU Zhulin
Department of Ophthalmology,the Second People’s Hospital of Yunnan Province,Yunnan Eye Hospital,Yunnan Eye Institute,Key Laboratory of Yunnan Province for the Prevention and Treatment of Ophthalmology,Provincial Innovation Team for Cataract and Ocular Fundus Disease,Yunnan Expert Workstation of Yaoke,Eye Disease Clinical Medical Research Center of Yunnan Province,Eye Disease Clinical Medical Center of Yunnan Province,Kunming 650021,Yunnan Province,China
关键词:
改良手术恶性青光眼虹膜周边前后节沟通术
Keywords:
modified surgerymalignant glaucomazonulo-hyaloido-vitrectomy
分类号:
R775.3
DOI:
10.13389/j.cnki.rao.2020.0008
文献标志码:
A
摘要:
目的 评价虹膜周边前后节沟通术治疗恶性青光眼及具有恶性青光眼倾向的原发性闭角型青光眼患者的临床效果。方法 收集我院2013年5月至2018年4月行虹膜周边前后节沟通术的88例(92眼)恶性青光眼及具有恶性青光眼倾向的原发性闭角型青光眼患者资料。观察手术前后眼压、最佳矫正视力、中央及周边前房深度及房角的变化情况,术后随访(25.7±13.5)个月。结果 恶性青光眼患者术前药物控制下眼压(34.27±12.95)mmHg(1 kPa=7.5 mmHg),术后第7天及末次随访眼压分别为(12.94±3.12)mmHg、(13.17±4.54)mmHg,与术前相比,差异均有统计学意义(均为P<0.01)。末次随访最佳矫正视力较术前明显提高(P<0.05)。有恶性青光眼倾向的原发性闭角型青光眼患者术前患眼药物控制下眼压 (20.50±7.41)mmHg,术后第7天及末次随访眼压分别为(13.92±4.39)mmHg、(15.25±4.54)mmHg,与术前相比,差异均有统计学意义(均为P<0.01)。术后最佳矫正视力与术前相比差异无统计学意义(P>0.05)。所有患者中央前房深度术前为 (1.67±0.33)mm,术后1个月为(3.35±0.35)mm,差异有统计学意义(P<0.01)。患者术前周边前房深度均<1/2 CT,术后89眼周边前房深度≥1 CT。术前72眼房角关闭范围>180°,术后房角完全开放38眼。结论 虹膜周边前后节沟通术可有效治疗恶性青光眼及具有恶性青光眼倾向的原发性闭角型青光眼患者。
Abstract:
Objective To evaluate the clinical efficacy of zonulo-hyaloido-vitrectomy for patients having malignant glaucoma or primary angle-closure glaucoma (PACG) with a tendency to malignant glaucoma.Methods The study included 92 eyes of 88 patients who were diagnosed with malignant glaucoma or PACG with a tendency to malignant glaucoma,and underwent zonulo-hyaloido-vitrectomy in our hospital from May 2013 to April 2018.The changes of intraocular pressure (IOP),best corrected visual acuity (BCVA),central anterior chamber depth,peripheral anterior chamber (PAC) depth and anterior chamber angle were observed before and after operation.The average follow-up time was (25.7±13.5)months.Results For patients with malignant glaucoma,mean IOP were (34.27±12.95)mmHg(1 kPa=7.5 mmHg) before operation,and had statistical differences with (12.94±3.12)mmHg 7 days after operation and (13.17±4.54)mmHg at the last follow-up (all P<0.01).BCVA at the last follow-up significantly improved (P<0.05).For patients diagnosed as PACG with a tendency to malignant glaucoma,mean IOP were (20.50±7.41)mmHg before operation,and had statistical differences with (13.92±4.39)mmHg 7 days after operation and (15.25±4.54)mmHg at the last follow-up (all P<0.01).There was no significant difference in BCVA before and after operation (P>0.05).For all patients,the average central anterior chamber depth was (1.67±0.33)mm before operation and (3.35±0.35)mm one month after operation,and statistical difference was found (P<0.01).The PAC depth was <1/2 CT for all patients before operation,and ≥1 CT for 89 eyes after operation.There were 72 eyes whose preoperative angle-closure range were >180°,and there were 38 eyes whose anterior chamber angle were fully opened after operation.Conclusion Zonulo-hyaloido-vitrectomy is an effective way for the treatment of malignant glaucoma and PACG with a tendency to malignant glaucoma.

参考文献/References:

[1] STUMPF T H,AUSTIN M,BLOOM P A,MCNAUGHT A,MORGAN J E.Transscleral cyclodiode laser photocoagulation in the treatment of aqueous misdirection syndrome[J].Ophthalmology,2008,115(11):2058-2061.
[2] SHAHID H,SALMON J F.Malignant glaucoma:A review of the modern literature[J].J Ophthalmol,2012,2012:852659.
[3] LIU X,LI M,CHENG B,MAO Z,ZHONG Y,WANG D,et al.Phacoemulsification combined with posterior capsulorrhexis and anterior vitrectomy in the management of malignant glaucoma in phakic eyes[J].Acta Ophthalmol,2013,91(7):660-665.
[4] TROPE G E,PAVLIN C J,BAU A,BAUMAL C R,FOSTER F S.Malignant glaucoma.Clinical and ultrasound biomicroscopic features[J].Ophthalmology,1994,101(6):1030-1035.
[5] DEBROUWERE V,STALMANS P,VAN CALSTER J,SPILEERS W,ZEYEN T,STALMANS I.Outcomes of different management options for malignant glaucoma:A retrospective study[J].Graefes Arch Clin Exp Ophthalmol,2012,250(1):131-141.
[6] DAVE P,SENTHIL S,RAO H L,GARUDADRI C S.Treatment outcomes in malignant glaucoma[J].Ophthalmology,2013,120(5):984-990.
[7] YU J,CHEN X,ZHOU D,SHEN J,WU Y,SUN Q.Clinical efficacy of ciliary ring incision combined with modified partial pars plana vitrectomy for malignant glaucoma[J].Med Sci Monit,2018,24:3916-3921.
[8] PAKRAVAN M,ESFANDIARI H,AMOUHASHEMI N,VEISI A,TORKIAN P,YAZDANI S.Mini-vitrectomy;a simple solution to a serious condition[J].J Ophthalmic Vis Res,2018,13(3):231-235.
[9] LOIS N,WONG D,GROENEWALD C.New surgical approach in the management of Pseudophakic malignant glaucoma[J].Ophthalmology,2001,108(4):780-783.
[10] SHARMA A,SII F,SHAH P,KIRKBY G R.Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes[J].Ophthalmology,2006,113(11):1968-1973.
[11] THOMPSON A C,CHALLA P.Prophylactic anterior vitrectomy during cataract surgery in eyes at increased risk for aqueous misdirection[J].Am J Ophthalmol Case Rep,2018,12:24-27.
[12] 由新英,王涛.超声乳化白内障吸出为主的睫状环阻滞性青光眼手术治疗模式探讨[J].眼科,2012,21(1):43-45.
YOU X Y,WANG T.The management model of malignant glaucoma with phacoemulsification cataract extraction[J].Ophthalmol CHN,2012,21(1):43-45.

相似文献/References:

[1]谭思敏 李瑞庄 黎宗汉 方林彬.原发性青光眼滤过术后发生恶性青光眼的危险因素分析[J].眼科新进展,2013,33(12):000.
[2]陈志敏.白内障超声乳化术后恶性青光眼临床分析[J].眼科新进展,2014,34(10):959.[doi:10.13389/j.cnki.rao.2014.0266]
[3]邵珺,姚勇. 23G微创玻璃体切割术应用于恶性青光眼的诊疗思路及疗效分析[J].眼科新进展,2015,35(6):546.[doi:10.13389/j.cnki.rao.2015.0148]
 SHAO Jun,YAO Yong. Efficacy of 23G minimally invasive vitrectomy for malignant glaucoma[J].Recent Advances in Ophthalmology,2015,35(1):546.[doi:10.13389/j.cnki.rao.2015.0148]
[4]罗晓阳,张良,孟倩丽,等.恶性青光眼的临床特征和危险因素分析[J].眼科新进展,2016,36(9):835.[doi:10.13389/j.cnki.rao.2016.0223]
 LUO Xiao-Yang,ZHANG Liang,MENG Qian-Li,et al.Analysis of clinical characteristics and risk factors of malignant glaucoma[J].Recent Advances in Ophthalmology,2016,36(1):835.[doi:10.13389/j.cnki.rao.2016.0223]

备注/Memo

备注/Memo:
云南省自然科学基金项目(编号:2017FB124);云南省眼科疾病防治研究重点实验室项目(编号:2017DG008);院士和领军人才培养项目(编号:2017HC010);院士专家工作站项目(编号:2017IC064);云南省卫生健康委员会医学后备人才培养计划(编号:H-2018023)
更新日期/Last Update: 2020-01-14